Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

OB/GYN Clinical Alert

RSS  

Articles

  • Primary HPV Screening: Ready for Prime Time?

    In this randomized, controlled trial of more than 25,000 women, participants with negative high-risk human papillomavirus testing at baseline had rates of CIN 3+ at 48 months that were lower compared to negative liquid-based cytology testing.

  • USPSTF Recommendation: Screening for Cervical Cancer

    The U.S. Preventive Services Task Force (USPSTF) recently updated its recommendations for cervical cancer screening. Practitioners currently following guidelines published by ASCCP (and supported by ACOG) will not find any discrepancies in the new USPSTF position

  • Can Hormone Therapy Prevent the Development of a ‘Dowager’s Hump’?

    Postmenopausal hormone therapy may reduce the risk of developing age-related hyperkyphosis, commonly known as a “Dowager’s hump,” and the benefit from hormone therapy use in early menopause may provide long-term benefit.

  • Screening for von Willebrand Disease: Warranted in Young Women With Heavy Menstrual Bleeding

    A large, retrospective cohort study using a national claims database revealed that fewer than 20% of young women with heavy menstrual bleeding were screened for von Willebrand disease.

  • A New Treatment for Early Pregnancy Loss

    In a recent trial, researchers found that pretreatment with mifepristone followed by treatment with misoprostol resulted in a higher likelihood of successful management of first-trimester pregnancy loss than treatment with misoprostol alone. The rate of surgical evacuation also was reduced in the mifepristone pretreatment arm compared to the misoprostol-alone arm.

  • Marijuana in Pregnancy

    A group of investigators posing as pregnant patients called marijuana dispensaries in Colorado to determine whether the stores’ staff recommended it for nausea and vomiting, if there were risks in pregnancy, and if providers should be consulted. The results were enlightening.

  • All About Cesarean Delivery

    A collection of articles and letters to the editors suggests that postpartum ultrasound evaluation of uterine wall thickness is of little value in predicting uterine wall complications in subsequent pregnancies, that two-layer closure of the uterus during cesarean delivery probably is better than single-layer closure, and that staple closure of the skin in patients with three or more previous cesarean deliveries is associated with more wound complications than suture closure.

  • Is Human Placentophagy Safe? What Patients Should Know

    In this cross-sectional study of U.S. women who delivered at home or at a birth center, 30.8% consumed their placenta, and, of those, 58% consumed the placenta in a raw form. The most common reason for consuming placenta was to prevent or treat postpartum depression. There was no association between placentophagy and neonatal hospitalization or death within six weeks of birth.

  • Recommendations for Surgical Treatment of Pelvic Organ Prolapse

    This is a summary of the 2017 International Consultation on Incontinence recommendations for surgical treatment of pelvic organ prolapse.

  • Management of Pain Associated With Intrauterine Device Placement

    With long-acting reversible contraceptive methods (intrauterine devices and implants) showing an increased proportion of users each year at the expense of permanent and short-acting hormonal methods, it makes sense to consider how best to improve the IUD placement experience, particularly for young nulliparous women.